Research output per year
Research output per year
Fingerprint
Dive into the research topics where Mingjiang Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia
Chen, Z., Zhou, K., Xue, J., Small, A., Xiao, G., Nguyen, L. X. T., Zhang, Z., Prince, E., Weng, H., Huang, H., Zhao, Z., Qing, Y., Shen, C., Li, W., Han, L., Tan, B., Su, R., Qin, H., Li, Y., Wu, D., & 20 others, Mar 29 2023, In: Science translational medicine. 15, 689, eabq8513.Research output: Contribution to journal › Article › peer-review
-
Activation of CD81+ skin ILC2s by cold-sensing TRPM8+ neuron-derived signals maintains cutaneous thermal homeostasis
Xu, M., Li, C., Yang, J., Ye, A., Yan, L., Yeoh, B. S., Shi, L., Kim, Y. S., Kang, J., Vijay-Kumar, M. & Xiong, N., May 2022, In: Science Immunology. 7, 72, eabe0584.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
CCL27 is a crucial regulator of immune homeostasis of the skin and mucosal tissues
Davila, M. L., Xu, M., Huang, C., Gaddes, E. R., Winter, L., Cantorna, M. T., Wang, Y. & Xiong, N., Jun 17 2022, In: iScience. 25, 6, 104426.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Differential regulation of CD8+CD86+ Vγ1.1+ γδT cell responses in skin barrier tissue protection and homeostatic maintenance
Li, C., Lin, Y. D., Wang, W. B., Xu, M., Zhang, N. & Xiong, N., Sep 2022, In: European Journal of Immunology. 52, 9, p. 1498-1509 12 p.Research output: Contribution to journal › Article › peer-review
-
HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia
Luo, H., Zhu, G., Eshelman, M. A., Fung, T. K., Lai, Q., Wang, F., Zeisig, B. B., Lesperance, J., Ma, X., Chen, S., Cesari, N., Cogle, C., Chen, B., Xu, B., Yang, F. C., So, C. W. E., Qiu, Y., Xu, M. & Huang, S., Feb 17 2022, In: Molecular Cell. 82, 4, p. 833-851.e11Research output: Contribution to journal › Article › peer-review
Open Access24 Scopus citations
Datasets
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Contributor), Khan, S. (Creator), Huo, Z. (Contributor), Lyu, D. (Contributor), Zhang, X. (Creator), Liu, X. (Contributor), Yuan, Y. (Contributor), Hromas, R. A. (Creator), Xu, M. (Contributor), Zheng, G. (Contributor) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Contributor), Khan, S. (Creator), Huo, Z. (Contributor), Lyu, D. (Contributor), Zhang, X. (Creator), Liu, X. (Contributor), Yuan, Y. (Contributor), Hromas, R. A. (Creator), Xu, M. (Contributor), Zheng, G. (Contributor) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Contributor), Khan, S. (Creator), Huo, Z. (Contributor), Lyu, D. (Contributor), Zhang, X. (Creator), Liu, X. (Contributor), Yuan, Y. (Contributor), Hromas, R. A. (Creator), Xu, M. (Contributor), Zheng, G. (Contributor) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Contributor), Khan, S. (Creator), Huo, Z. (Contributor), Lyu, D. (Contributor), Zhang, X. (Creator), Liu, X. (Contributor), Yuan, Y. (Contributor), Hromas, R. A. (Creator), Xu, M. (Contributor), Zheng, G. (Contributor) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547, https://springernature.figshare.com/articles/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Contributor), Khan, S. (Creator), Huo, Z. (Contributor), Lyu, D. (Contributor), Zhang, X. (Creator), Liu, X. (Contributor), Yuan, Y. (Contributor), Hromas, R. A. (Creator), Xu, M. (Contributor), Zheng, G. (Contributor) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset